Loading...
OTCM
NNRX
Market cap816kUSD
Nov 03, Last price  
0.00USD
Name

Nutranomics Inc

Chart & Performance

D1W1MN
OTCM:NNRX chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
-100.00%
000002,402,7691,789,32559,5448711,756,9182,846,7860
Net income
0k
P
-23,172-39,125-14,247-14,839-23,567-2,172,242-1,217,479-2,238,452-950,795-1,888,747-6,629,7750
CFO
0k
P
-11,039-24,243-5,644-9,127-25,691-633,360-430,894-167,847-570,270-1,922,485-4,524,8430

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nutranomics, Inc. focuses on the research, development, and marketing of health-focused nutritional products. Their extensive catalog features nearly 500 distinct dietary supplements, encompassing formulations of vitamins, minerals, herbal remedies, and probiotics. Beyond its product offerings, the company provides innovative services, such as its Nutritional Blood Analysis—a diagnostic tool enabling customers to observe their blood cells live on a video monitor—and the patented Assimilation Enhancing System, which is engineered to optimize nutrient absorption. Additionally, Nutranomics delivers comprehensive educational resources, including various forms of analysis, training programs, professional certifications, and group presentations, catering to both individuals and industry experts. The distribution of its products occurs globally through a network of sales representatives across North America and Asia, alongside availability in retail stores. Nutranomics, Inc. also maintains a strategic alliance with Terra-Formance, LLC. Established in 1995, the company is based in Salt Lake City, Utah.
IPO date
Oct 19, 2012
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑072022‑072021‑072020‑072019‑07
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT